DOX/RAcNPs synergized with GM-CSF to enhance immune responses, and rats treated with DOX/RAcNPs@gel displayed reduced tumor volume compared with controls or TMZ-treated rats, although all animals died within 32 days (a fact attributed to the insufficient immune infiltrates in the tumor site) [981]. This evidence concerns the gene CSF2 and neoplasm.